Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$860,000 |
 |
ZomedicaZOM |
$4.9M |
 |
Johnson & JohnsonJNJ |
-$64M |
 |
Mind Medicine (MindMed)MNMD |
-$52M |
 |
ModernaMRNA |
-$160B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| BOERNER CHRISTOPHER S. | Feb 20, 2025 | Buy | 2,000 | $55.048 | $110,000 |
| Hirawat Samit | Feb 14, 2025 | Buy | 1,823 | $54.84 | $100,000 |
| Holzer Phil M | Nov 4, 2024 | Sell | 700 | $55.615 | $39,000 |
| Hirawat Samit | Nov 1, 2024 | Buy | 1,830 | $54.675 | $100,000 |
| BOERNER CHRISTOPHER S. | Dec 5, 2023 | Buy | 2,000 | $49.78 | $100,000 |
| BOERNER CHRISTOPHER S. | Nov 28, 2023 | Buy | 3,071 | $48.86 | $150,000 |
| Samuels Theodore R. II | Nov 20, 2023 | Buy | 8,500 | $49.81 | $420,000 |
| Powell Ann | Aug 24, 2023 | Sell | 17,986 | $61.25 | $1.1M |
| Plenge Robert M | Aug 3, 2023 | Sell | 732 | $61.14 | $45,000 |
| VESSEY RUPERT | May 3, 2023 | Sell | 50,385 | $67.06 | $3.4M |
What's the latest insider transaction for Bristol-Myers Squibb?
The most recent insider transaction for Bristol-Myers Squibb was conducted by BOERNER CHRISTOPHER S., who sold 2,000 shares on February 20, 2025 at a price of $55.05 per share.
Which insider bought the most BMY stock over the last two years?
Samuels Theodore R. II has bought the most BMY stock in the last 2 years, with a total value of $420,000.
Which insider has sold the most BMY stock over the last two years?
VESSEY RUPERT has sold the most BMY stock in the last 2 years, with a total value of $3.4M.
What is the total value of insider transactions for Bristol-Myers Squibb (BMY) in the last 2 years?
The total value of insider transactions for Bristol-Myers Squibb in the last 2 years is negative, amounting to -$3.6M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Bristol-Myers Squibb's market confidence?
Over the last 2 years, insider transactions for Bristol-Myers Squibb have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
